Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1613 1615 1621 1674 3783
This examiner grants 28% of resolved cases
Lyndsey Marie Beckhardt serves in Art Unit 1613 of Tech Center 3700. She has managed 568 resolved cases with an allowance rate of 27.8%. This 27.8% allowance rate provides a baseline for the probability of a grant on her docket. Practitioners can use this figure to evaluate the likelihood of success for applications in this technology area. The 568 resolved cases suggest a rigorous examination pattern for this examiner.
The interview lift is 48.0%. This metric indicates that cases with an interview have a significantly higher probability of allowance than those without an interview. When compared to the 27.8% allowance rate, the 48.0% lift suggests that direct communication is a critical factor in reaching a positive outcome. For the 568 resolved cases, interviews appear to be an exceptionally productive tactical choice. This 48.0% lift is a key indicator of examiner responsiveness.
The median days to allowance is 1456. This timeline represents the middle point of pendency for granted applications. Practitioners should expect a prosecution cycle around 1456 days. These metrics offer a data-grounded view of the examiner's procedural habits and the impact of interviews on the allowance rate. The 1456-day duration, combined with the interview lift, provides a set of benchmarks for navigating Art Unit 1613.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18327140 | POWDER FOR ACHIEVING HEMOSTASIS | Final Rejection | Boston Scientific Scimed, Inc. |
| 18727872 | Antibacterial Resin and Molded Body Comprising Same | Final Rejection | LG Chem, Ltd. |
| 17904553 | CROSSLINKED POLY(LACTIDE-CO-GLYCOLIDE) (PLGA)-DIMETHACRYLATE COATINGS AND METHODS OF USE | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18012614 | COLLAGEN-BIOGLASS ARTICLES AND METHODS OF MAKING THE SAME | Non-Final OA | Solventum Intellectual Properties Company |
| 18099810 | DELIVERY DEVICES AND METHODS FOR MAKING THE SAME | Final Rejection | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 18727765 | SKIN MICROBIOME FRIENDLY SUNSCREENS | Non-Final OA | BASF SE |
| 18906741 | Hair Treatment Compositions Having Anti-Dandruff Action | Final Rejection | Henkel AG & Co. KGaA |
| 17785880 | TINTING CONDITIONER HAVING IMPROVED DYEING PERFORMANCE | Final Rejection | Henkel AG & Co. KGaA |
| 18408546 | THERAPEUTIC AGENTS AND THEIR USE FOR TREATING CHRONIC WOUNDS | Non-Final OA | President and Fellows of Harvard College |
| 17914134 | METHODS FOR TISSUE REGENERATION AND KITS THEREFOR | Final Rejection | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
| 18157371 | ANTI-FOULING IMPLANTABLE MATERIAL AND METHOD OF MAKING | Non-Final OA | Edwards Lifesciences Corporation |
| 18044233 | PHARMACEUTICAL COMPOSITION COMPRISING CHLOROQUINE AND USES THEREOF | Non-Final OA | Philip Morris Products S.A. |
| 18401930 | ANTI-POLLUTION ECO-FRIENDLY MATERIAL AND METHOD FOR PREPARING THE SAME | Non-Final OA | RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY |
| 17991937 | Ionic Polymers For Medical Device Applications | Final Rejection | Becton, Dickinson and Company |
| 18634454 | FORMATION OF STABLE SUBMICRON PEPTIDE OR PROTEIN PARTICLES BY THIN FILM FREEZING | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18017583 | COMPOSITION FOR PREVENTING ADHESION | Non-Final OA | The University of Tokyo |
| 18722151 | COSMETIC COMPOSITION COMPRISING A NATURAL RESIN | Non-Final OA | L'OREAL |
| 18716673 | COMPOSITION COMPRISING A POLYHYDROXYALKANOATE COPOLYMER WITH A LONG HYDROCARBON-BASED CHAIN BEARING IONIC GROUP(S), AND METHOD FOR TREATING KERATIN MATERIALS USING THE COMPOSITION | Non-Final OA | L'Oreal |
| 18704717 | COMPOSITION COMPRISING A PARTICULAR OXIDATION DYE PRECURSOR AND TWO PARTICULAR ACIDS | Non-Final OA | L'OREAL |
| 18726929 | CMT-3 FORMULATIONS AND METHODS OF USING THE SAME | Non-Final OA | The Research Foundation for the State University of New York |
| 18010653 | DRUG-LOADED MEDICAL DEVICE AND PREPARATION METHOD, DRUG BALLOON, AND DRUG COATING PREPARATION METHOD | Non-Final OA | SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD. |
| 18272705 | PATCH COMPRISING SENSING COMPONENTS | Non-Final OA | ETH ZURICH |
| 18577168 | COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY | Non-Final OA | ASTRAZENECA PHARMACEUTICALS LP |
| 17916215 | NANOFIBER-ENABLED ENCAPSULATION DEVICES AND USES THEREOF | Final Rejection | CORNELL UNIVERSITY |
| 17906433 | IMPLANTABLE CELL CHAMBER DEVICE AND USES THEREOF | Final Rejection | Takeda Pharmaceutical Company Limited |
| 17273883 | A MEDICAL TUBULAR DEVICE | Non-Final OA | BIOMODICS APS |
| 16604173 | SMECTITE SUSPENSION LIQUID COMPOSITION AND METHOD FOR PREPARING SAME | Non-Final OA | Liaoning Daewoong Pharmaceutical Co., Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy